相关实验视频
Updated: May 11, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
黄黄在治疗糖尿病伤口中的机制:一个网络药理学和实验研究研究
Jie Zhang1, Yan Shi1, Jiaqiang Wang1
1Department of Burn, Shanghai Burn Institute, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
黄黄通过增强血管内皮细胞增殖和通过HIF-1α/VEGF-α通路促进血管化,同时通过NF-κB信号来抑制炎症,从而加速糖尿病伤口愈合.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传统中国医药 传统中国医药
- 伤口愈合 治愈 伤口愈合
- 糖尿病并发症 糖尿病并发症
背景情况:
- 黄黄 (HH) ,是七种传统中医药的混合物,显示出治疗伤口的临床前景.
- 在糖尿病伤口治疗中,HH的疗效背后的精确药理机制需要阐明.
研究的目的:
- 调查HH在促进糖尿病伤口愈合方面的潜在作用机制.
- 为了识别关键的化学成分,分子点和信号通路,参与HH的治疗效果.
主要方法:
- 使用超高性能液体染色学-四极飞行时间质谱学对HH蒸进行化学分析.
- 网络药理学用于目标预测,其次是基因本体学和途径丰富分析 (DAVID).
- 预测目标和途径的体内和体外实验验证.
主要成果:
- 确定了53种化学成分,其中关键的化合物包括四水,埃莫丁和柏柏林.
- 网络药理学揭示了21个核心向基因,涉及细胞增殖,迁移和炎症调节.
- 脱HH促进了血管内皮细胞的增殖和管形成,高调HIF-1α/VEGF-α信号传递,降调炎症标志物 (IL-6,TNF-α,IL-1β) 和NF-κB通路激活.
结论:
- 黄可以通过多组分,多目标和多途径的方法促进糖尿病伤口愈合.
- 治疗效果通过增强血管内皮细胞增殖 (cyclinD1),改善血管化 (HIF-1α/VEGF-α) 和抑制炎症 (NF-κB) 的介导.
- 脱HH代表了糖尿病伤口管理的有前途的治疗策略.
更多相关视频
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
相关概念视频
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucose Absorption Into the Small Intestine
Diabetes Insipidus II: Pathophysiology
Hypoglycemia
Diabetic Retinopathy
Diabetic Neuropathy